Oncology & Cancer

High response rate in phase I/II paediatric brain cancer trial

A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in ...

Oncology & Cancer

Improving cancer treatment through better imaging technologies

Since January 2014, the HELICOID project has been developing hyperspectral imaging technologies capable of differentiating between healthy and diseased tissues. The February 2015 meeting in Brussels enabled project partners ...

Oncology & Cancer

Immune checkpoint inhibitors may work in brain cancers

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

Oncology & Cancer

How the EU could help more children survive cancer

A leading expert in childhood cancer at The University of Nottingham is spearheading a Europe-wide lobby of the European Parliament to try to make it easier for doctors to develop and test new treatments on children and young ...

page 20 from 24